ReviewTherapeutic advances in hematology2017

Vosaroxin in relapsed/refractory acute myeloid leukemia: efficacy and safety in the context of the current treatment landscape.

Valeriy Sedov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.